PHASE-I STUDY AND CLINICAL PHARMACOLOGICAL STUDY OF MUROCTASIN

被引：0
|
作者：
ICHIHARA, N
KANAZAWA, R
SASAKI, S
ONO, K
OTANI, T
YAMAGUCHI, F
UNE, T
机构：
[1] KOUSEI GEN HOSP,DEPT PREVENT MED,TOKYO,JAPAN
[2] KYOUNDO HOSP,SASAKI INST,DEPT INTERNAL MED,TOKYO,JAPAN
[3] DAIICHI SEIYAKU CO LTD,RES INST,16-13 KITAKASAI 1 CHOME,EDOGAWA KU,TOKYO 134,JAPAN
来源：
ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 1988年 / 38-2卷 / 7A期
关键词：
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：1043 / 1069
页数：27
相关论文
共 50 条
  • [21] PROLONGED INFUSION OF HEXAMETHYLENE BISACETAMIDE (HMBA) - PHASE-I AND PHARMACOLOGICAL STUDY
    MCGUIRE, WP
    ROWINSKY, EK
    ETTINGER, DS
    GROCHOW, LB
    LUK, GD
    DONEHOWER, RC
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 193 - 193
  • [22] A PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF MERBARONE (M)
    HAINES, I
    WALSH, TD
    WARRELL, RP
    STEVENS, YW
    LOWENTHAL, D
    WILLIAMS, L
    SYKES, M
    YOUNG, CW
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 192 - 192
  • [23] A PHASE-I STUDY OF INTRAVENOUS IODODEOXYURIDINE AS A CLINICAL RADIOSENSITIZER
    KINSELLA, TJ
    RUSSO, A
    MITCHELL, JB
    COLLINS, JM
    ROWLAND, J
    WRIGHT, D
    GLATSTEIN, E
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1985, 11 (11): : 1941 - 1946
  • [24] PHASE-I AND PHARMACOLOGICAL STUDY OF HEXAMETHYLENE BISACETAMIDE IN PATIENTS WITH ADVANCED CANCER
    ROWINSKY, EK
    ETTINGER, DS
    GROCHOW, LB
    BRUNDRETT, RB
    CATES, AE
    DONEHOWER, RC
    JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (12) : 1835 - 1844
  • [25] BENZNIDAZOLE WITH CCNU - A CLINICAL PHASE-I TOXICITY STUDY
    ROBERTS, JT
    BLEEHEN, NM
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1985, 11 (02): : 331 - 334
  • [26] DEOXYSPERGUALIN - PHASE-I CLINICAL, IMMUNOLOGICAL AND PHARMACOKINETIC STUDY
    HAVLIN, KA
    KUHN, JG
    KOELLER, J
    BOLDT, DH
    CRAIG, JB
    BROWN, TD
    WEISS, GR
    CAGNOLA, J
    PHILLIPS, J
    HARMAN, G
    HARDY, J
    VONHOFF, DD
    ANTI-CANCER DRUGS, 1995, 6 (02) : 229 - 236
  • [27] PHASE-I CLINICAL-PHARMACOLOGIC STUDY OF MERBARONE
    WARRELL, RP
    DIMAGGIO, JJ
    MUINDI, J
    YOUNG, CW
    YALDEI, S
    BALTZER, L
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 189 - 189
  • [28] PHASE-I STUDY OF PENTAMETHYLMELAMINE
    GOLDBERG, RS
    GRIFFIN, JP
    MCSHERRY, JW
    KRAKOFF, IH
    CANCER TREATMENT REPORTS, 1980, 64 (12): : 1319 - 1322
  • [29] PHASE-I STUDY OF PYRAZOFURIN
    SALEM, PA
    BODEY, GP
    BURGESS, MA
    MURPHY, WK
    FREIREICH, EJ
    CANCER, 1977, 40 (06) : 2806 - 2809
  • [30] NEOCARZINOSTATIN - PHASE-I STUDY
    GRIFFIN, T
    COMIS, RL
    LOKICH, J
    CANELLOS, G
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 302 - 302
12345